About this trial
Given the close correlation reported in the literature between onset and progression of tendon pathology in subjects affected by the alteration of metabolic disorders such as obesity, diabetes mellitus and lipidic metabolic alterations, with the present study the association between the nutritional state, metabolic profile and clinical outcome of patients following treatment with blood-derived orthobiological for shoulder tendinopathies will be evaluated.
The primary aim of this study is to identify the proportion of tendinopatic patients responsive and non-responsive to treatment with "Platelet rich growth factors" PRGF at six months follow up and the correlation with their nutritional status.
Eligibility criteria
Qualifiers
Male and female
Age ≥18 years and ≤ 70 years
Patients presenting shoulder tendinopathy
Signing of the Informed Consent of the Regain observational study
Disqualifiers
Pregnancy (ascertained by self-declaration), breastfeeding
Inability to follow the study protocol
Heart, kidney, oncological disease
Neuropsychiatric disease
Trial design
Treatments tested in this trial
- Platelet rich growth factor injection (autologous product)